| 沸点 | 130°C/14.3mmHg |
| 别名 | ; |
3,3'-二氟联苯
3,3'-Difluorobiphenyl （订货以英文为准）
编号：D155058
CAS号：396-64-5
分子式：C12H8F2
分子量：190.19
| 产品名称 | 3,3'-Difluorobiphenyl |
| 中文名称 | 3,3'-二氟联苯 |
| CAS号 | 396-64-5 |
| MDL编码 | D155058 |
| 分子式（M.F.） | C12H8F2 |
| 分子量（M.W.） | 190.19 |
| 储存条件 | 避光 |
| Reaxys-RN | 1804802 |
| RTECS | MA3750500 |
| 闪点（摄氏） | 87°C(lit.) |
技术规格
| Background: | FKHR belongs to the forkhead family of transcription factors, which are characterized by a distinct forkhead domain. It may play a role in myogenic growth and differentiation. The mammalian DAF-16-like transcription factors, FKHR, FKHRL1, and AFX, function as key regulators of insulin signaling, cell cycle progression, and apoptosis downstream of phosphoinositide 3-kinase. Gene activation through binding to insulin response sequences has been essential for mediating these functions. D-type Cyclins (in Class III) is required for FKHR mediated inhibition of cell cycle progression and transformation. FKHR gene is mapped to chromosome 13q14 |
| Applications: | WB, IHC, IF |
| Name of antibody: | FOXO1 (Phospho-Ser319) |
| Immunogen: | Synthetic peptide of human FOXO1 (Phospho-Ser319) |
| Full name: | forkhead box O1 (Phospho-Ser319) |
| Synonyms： | FKH1; FKHR; FOXO1A |
| SwissProt: | Q12778 |
| IHC positive control: | Human breast carcinoma |
| IHC Recommend dilution: | 50-100 |
| WB Predicted band size: | 70 kDa |
| WB Positive control: | NIH/3T3 cells untreated or treated with serum starvation |
| WB Recommended dilution: | 500-1000 |
| IF Positive control: | Hela cells |
| IF Recommended dilution | 100-200 |
搜索质检报告(COA)
搜索MSDS
相关产品
党沛 
